4/A//SEC Filing
Ferrara Robert L 4/A
Accession 0001683168-25-006986
CIK 0001533040other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 4:02 PM ET
Size
5.8 KB
Accession
0001683168-25-006986
Insider Transaction Report
Form 4/AAmended
Ferrara Robert L
Director
Transactions
- Award
Common Stock, $.0001 par value
2025-09-11+23,100→ 38,766 total
Footnotes (4)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
- [F3]The number of reported securities has been adjusted to reflect prior reverse stock splits.
- [F4]This amended Form 4 corrects the number of stock options reported in the original Form 4 filed on September 15, 2025. The original filing incorrectly stated that 23,000 restricted stock units were granted. The correct number of restricted stock units granted was 23,100. Securities beneficially owned changed from 38,666 to 38,766.
Documents
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001792987
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 4:02 PM ET
- Size
- 5.8 KB